Table of Contents Author Guidelines Submit a Manuscript
Erratum

An erratum for this article has been published. To view the erratum, please click here.

International Journal of Endocrinology
Volume 2013, Article ID 587140, 9 pages
http://dx.doi.org/10.1155/2013/587140
Clinical Study

Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)

1Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa-Shi, Saitama 359-8513, Japan

Received 23 May 2013; Accepted 16 July 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 Takumi Hirata et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Takumi Hirata, Kengo Tomita, Toshihide Kawai, et al., “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY),” International Journal of Endocrinology, vol. 2013, Article ID 587140, 9 pages, 2013. https://doi.org/10.1155/2013/587140.